Exercise training and losartan improve endothelial function in heart failure rats by different mechanisms

Scandinavian Cardiovascular Journal

Volumn 47, Issue 3, 2013, Pages 160-167

  Kemi, Ole Johan ^a,b   Haram, Per Magnus ^b,c   Høydal, Morten Andre ^b   Wisløff, Ulrik ^b   Ellingsen, Øyvind ^b,c  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Endothelium; Endothelium derived hyperpolarizing factor; Exercise training; Heart failure; Losartan; Myocardial infarction; Nitric oxide

Indexed keywords

ACETYLCHOLINE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; LOSARTAN; NITRIC OXIDE; PLACEBO; PROSTACYCLIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; EXERCISE; FEMALE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSDUCER; UPREGULATION; VASODILATATION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BIOLOGICAL FACTORS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; EXERCISE THERAPY; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; LOSARTAN; NITRIC OXIDE; PROSTAGLANDINS I; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; TIME FACTORS; VASODILATION; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 84878122123     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.3109/14017431.2012.754935     Document Type: Article

References (23)

1. V, Erbs S, Linke A, Krankel N, Shu Y, et al. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation. 2003 ; 107: 3152-8.
2. Hambrecht R, G ielen S, L inke A, F iehn E, Y u J, W alther C, et al. Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: A randomized trial. JAMA. 2000; 283: 3095-101.
3. Fitzgerald S M, B ashari H, C ox J A, P arkington H C, E vans RG. Contributions of endothelium-derived relaxing factors to control of hindlimb blood fl ow in the mouse in vivo. Am J Physiol Heart Circ Physiol. 2007; 293: H1072-82.
4. Hambrecht R, W olf A, G ielen S, L inke A, H ofer J, E rbs S, et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med. 2000; 342: 454-60.
5. Mann DL, D eswal A, B ozkurt B, B orre-Amione G. N ew therapeutics for chronic heart failure. Annu Rev Med. 2002; 53: 59-74.
6. Lindsay DC, J iang C, B runotte F, A damopoulos S, C oats A J, Rajagopalan B, et al. Impairment of endothelium dependent responses in a rat model of chronic heart failure: Effects of an exercise training protocol. Cardiovasc Res. 1992; 26: 694-7.
7. Wisloff U, S toylen A, L oennechen JP, B ruvold M, R ognmo M, Haram PM, et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: A randomized study. Circulation. 2007; 115: 3086-94.
8. Pitt B, P oole-Wilson P A, S egal R, M artinez FA, D ickstein K, Camm AJ, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial-The Losartan Heart Failure Survival Study ELITE II. Lancet. 2000; 355: 1582-7.
9. Pitt B, Segal R, Martinez FA, Meurers G, Cowley A J, Thomas I, et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet. 1997; 349: 747-52.
10. Ferrario CM. U se of angiotensin II receptor blockers in animal models of atherosclerosis. Am J Hypertens. 2002; 15: 9S-13S
11. Kemi OJ, H oydal MA, H aram PM, G arnier A, F ortin D, Ventura-Clapier R, et al. Exercise training restores aerobic capacity and energy transfer systems in heart failure treated with losartan. Cardiovasc Res. 2007; 76: 91-9.
12. Kemi O J, M acQuaide N, H oydal M A, E llingsen O, S mith G L, Wisloff U. Exercise training corrects control of spontaneous calcium waves in hearts from myocardial infarction heart failure rats. J Cell Physiol. 2012; 227: 20-6.
13. Kemi OJ, H aram PM, W isloff U, E llingsen O. A erobic fi tness is associated with cardiomyocyte contractile capacity and endothelial function in exercise training and detraining. Circulation. 2004; 109: 2897-904.
14. Bauersachs J, P opp R, H ecker M, S auer E, F leming I, B usse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation. 1996; 94: 3341-7.
15. Crozier I, I kram H, A wan N, C leland J, S tephen N, D ickstein K, et al. Losartan in heart failure. Hemodynamic effects and tolerability. Losartan hemodynamic study group. Circulation. 1995; 91: 691-7.
16. Kubo SH, R ector T S, B ank AJ, R aij L, K raemer MD, T adros P, et al. Lack of contribution of nitric oxide to basal vasomotor tone in heart failure. Am J Cardiol. 1994; 74: 1133-6.
17. Furfi ne ES, H armon MF, P aith JE, G arvey EP. S elective inhibition of constitutive nitric oxide synthase by L-NG-nitroarginine. Biochemistry. 1993; 32: 8512-7.
18. Haram PM, A dams V, K emi OJ, B rubakk AO, H ambrecht R, Ellingsen O, Wisl ø ff U. Time-course of endothelial adaptation following acute and regular exercise. Eur J Cardiovasc Prev Rehabil. 2006; 13: 585-91.
19. Feletou M, V anhoutte PM. E ndothelium-dependent hyperpolarizations: Past beliefs and present facts. Ann Med. 2007; 39: 495-516.
20. Yang G, W u L, J iang B, Y ang W, Q i J, C ao K, et al. H 2 S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine ©-lyase. Science. 2008; 322: 587-90.
21. Malmsjo M, Bergdahl A, Zhao X H, Sun X Y, Hedner T, Edvinsson L, Erlinge D. Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF-dilatation in congestive heart failure. Cardiovasc Res. 1999; 43: 200-9.
22. Westendorp B, S choemaker RG, v an Gilst WH, B uikema H. Improvement of EDHF by chronic ACE inhibition declines rapidly after withdrawal in rats with myocardial infarction. J Cardiovasc Pharmacol. 2005; 46: 766-72.
23. Mollnau H, W endt M, S zocs K, L assegue B, S chulz E, O elze M, et al. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res. 2002; 90: E58-65.